REMEMBER: SHELF WILL BUY_OUT ANY TOXIC DEBT LEFT !!
They did a FIXED PRICE shelf that should be fully subscribed and "sold" any day here now - and IF there's any toxic debt conversions left, QNTA has the right to buy-out the remaining balances and retire those notes.
Their filing and PR said just that- we can and will use the $5 mil shelf to restructure legacy debt left over from the prior mgt blah blah.
SO, the 5 cent fixed price offering may not be the hottest price but this is an ULTRA LOW FLOAT STOCK and even w/ 100 mil shares added AT A FIXED PRICE it is STILL a ultra low float stock.
The convertible notes "should be" close to done - but they can use a small portion (say $300K or whatever) left using the non toxic shelf offering and retire that debt and still have a SHIT LOAD of working capital left - for their on-going major new efforts to rebrand, conduct final clinical IND efforts etc.
They can BUY OUT any toxic note remaining and still have about $4.5 MILLION in new working capital left = PLENTY to kick this new show off into high gear and THEN grow revenues rapidly and become "self funding" before 2021 is over :)
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
